In this regard, one can predict that pollutants acting as ERα agonists and ERβ antagonists in a particular cellular context (e.g., ferutinine in HeLa cells) should stimulate cell proliferation and tumor growth more effectively than compounds activating more ERβ than ERα. The gene discussed is ESR2; the disease is neoplasm.